Browse the full record of transactions filed by 김용주. Director active across 1 company, notably 리가켐바이오. Aggregated, 15 filings have been recorded. Regulator: DART (FSS). The full history is free.
Declarations 15 total
● Executives · 1 Jul 2024 (filed) · 리가켐바이오 940 shares DART:20240701000453 Ideal exit: 28 Mar 2025 (T+270) ● Executives · 17 Jan 2024 (filed)
● Executives · 1 Dec 2023 (filed) · 리가켐바이오 940 shares DART:20231201000226 Ideal exit: 27 Aug 2024 (T+270) ● Executives · 18 Aug 2023 (filed) · 리가켐바이오 940 shares DART:20230818000239 Ideal exit: 14 May 2024 (T+270) ● Executives · 2 May 2023 (filed) · 리가켐바이오 940 shares DART:20230502000859 Ideal exit: 27 Jan 2024 (T+270) ● Executives · 5 Apr 2023 (filed) · 리가켐바이오 940 shares DART:20230405002933 Ideal exit: 31 Dec 2023 (T+270) ● Executives · 12 Dec 2022 (filed) · 리가켐바이오 940 shares DART:20221212000211 Ideal exit: 8 Sept 2023 (T+270) ● Executives · 14 Jul 2022 (filed) · 리가켐바이오 940 shares DART:20220714000463 Ideal exit: 10 Apr 2023 (T+270) ● Executives · 11 May 2022 (filed) · 리가켐바이오 940 shares DART:20220511000425 Ideal exit: 5 Feb 2023 (T+270) ● Executives · 9 Dec 2021 (filed) · 리가켐바이오 940 shares DART:20211209000195 Ideal exit: 5 Sept 2022 (T+270) ● Executives · 6 Oct 2021 (filed) · 리가켐바이오 940 shares DART:20211006000192 Ideal exit: 3 Jul 2022 (T+270) ● Executives · 7 Sept 2021 (filed) · 리가켐바이오 940 shares DART:20210907000150 Ideal exit: 4 Jun 2022 (T+270) ● Executives · 7 Sept 2021 (filed) · 리가켐바이오 940 shares DART:20210907000169 Ideal exit: 4 Jun 2022 (T+270) ● Executives · 5 Aug 2021 (filed) · 리가켐바이오 940 shares DART:20210805000215 Ideal exit: 2 May 2022 (T+270) ● Executives · 23 Jul 2021 (filed) · 리가켐바이오 940 shares DART:20210723000431 Ideal exit: 19 Apr 2022 (T+270)